Pain and Pain Management

  • Richard Payne
  • Gavril W. Pasternak


The principles of pain management1 are similar for young and old patients (Table 45.1). However, the geriatric population is more likely to experience a number of specific pain problems. Treatment also must be tailored to the elderly patient due to differences in sensitivities to many analgesic agents. This chapter will review the general concept of pain in elderly persons, starting with current knowledge that concerns the role of the nervous system in the modulation of nociperception and the assessment and treatment of specific pain problems in the elderly patient, emphasizing features that are unique to this population, but stressing the importance of a careful evaluation of the pain complaint and the aggressive but judicious use of all available therapeutic modalities for the prompt relief of pain with the minimum amount of adverse effects. Drug therapy for pain will be emphasized, particularly the issues of altered pharmacokinetic and pharmacodynamic responses to a wide variety of pharmacologic agents in the geriatric population (see also Chapter 7).


Pain Syndrome Cancer Pain Lumbar Spinal Stenosis Postherpetic Neuralgia Compute Tomogra 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Payne R, Foley KM. Advances in the management of cancer pain. Cancer Treat Rep 1984; 68: 173–183.PubMedGoogle Scholar
  2. 2.
    Merskey H. Classification of chronic pain: description of chronic pain syndromes and definitions of pain terms. Pain 1986; 3 (suppl): S217.Google Scholar
  3. 3.
    Foley KM, Sundaresan N. Management of cancer pain. In: Devita VT, Hellman S, Rosenberg SA, eds. Principles and Practice of Oncology. Philadelphia, Pa: JB Lippincott Co; 1985: 1940–1941.Google Scholar
  4. 4.
    Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology 1988; 68: 571–590.PubMedCrossRefGoogle Scholar
  5. 5.
    Fields HL. Pain. New York, NY: McGraw-Hill International Book Co; 1987.Google Scholar
  6. 6.
    Sinclair DC, Weddel G, Feindel WH. Referred pain and associated phenomena. Brain 1948; 71: 184–211.PubMedCrossRefGoogle Scholar
  7. 7.
    Albe-Fessard D, Condes-Lara M, Sanderson P, et al. Tentative explaination of the special role played by the areas of paleospinothalamic projection in patients with deafferentation pain syndromes. In: Kurger L, Liebeskind JC, eds. Advances in Pain Research and Therapy. New York, NY: Raven Press; 1984; 6: 167–182.Google Scholar
  8. 8.
    Payne R. Neuropathic pain syndromes, with special reference to causalgia and reflex sympathetic dystrophy. Clin J Pain 1986; 2: 59–73.CrossRefGoogle Scholar
  9. 9.
    Meyer RA, Campbell JN. Myelinated nociceptive afferent account for the hyperalgesia that follows a burn to the hand. Science 1981; 213: 1527–1529.PubMedCrossRefGoogle Scholar
  10. 10.
    Wall PD, McMahon SB. Microneurography and its relation to perceived sensation: a critical review. Pain 1985; 21: 209–229.PubMedCrossRefGoogle Scholar
  11. 11.
    Torebjork HE. Activity in C nociceptors and sensation. In: Kenshalo DR, ed. Sensory Function of the Skin of Humans. New York, NY: Plenum Press; 1979: 313–325.CrossRefGoogle Scholar
  12. 12.
    Campbell JN, Mayer RA. Primary afferents and hyperalgesia. In: Yaksh TL, ed. Spinal Afferent Processing. New York, NY: Plenum Press; 1986: 59–81.Google Scholar
  13. 13.
    Milne RJ, Foreman RD, Giesler GJ, Willis WD. Convergence of cutaneous and pelvic visceral nociceptive inputs onto primate spinothalamic neurons. Pain 1981; 11: 163–181.PubMedCrossRefGoogle Scholar
  14. 14.
    Culp WJ, Ochoa J. Abnormal Nerves and Muscles as Impulse Generators. New York, NY: Oxford University Press Inc; 1982.Google Scholar
  15. 15.
    Tasker RR, Tsuda T, Hawrylyshyn P. Clinical neuro-physiological investigation of deafferentation pain. In: Bonica JJ, ed. Advances in Pain Research and Therapy. New York, NY: Raven Press; 1983; 5: 718–738.Google Scholar
  16. 16.
    Nathan PW. Pain and the sympathetic nervous system. J Auton Nery Syst 1983; 7: 363–370.CrossRefGoogle Scholar
  17. 17.
    Dubner R, Bennett GJ. Spinal and trigeminal mechanisms of nociception. Ann Neurol 1983; 6: 381–418.Google Scholar
  18. 18.
    Melzack R, Wall PD. Pain mechanism: a new theory. Science 1965; 150: 971–978.PubMedCrossRefGoogle Scholar
  19. 19.
    Kenshalo DR, Isensee O. Response of primate SI cortical neurons to noxious stimuli. J Neurophysiol 1983; 50: 1479–1496.PubMedGoogle Scholar
  20. 20.
    Young GB, Blume WT. Painful epileptic seizures. Brain 1983; 106: 537–554.PubMedCrossRefGoogle Scholar
  21. 21.
    Bausbaum AI. The generation and control of pain. In: Rosenberg, RN, ed. The Clinical Neurosciences. New York, NY: Churchill Livingstone Inc; 1983: 301–332.Google Scholar
  22. 22.
    Levy RM, Lamb S, Adams JE. Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature. Neurosurgery 1987; 21: 885–893.PubMedCrossRefGoogle Scholar
  23. 23.
    Foley KM. Adjuvant analgesic drugs in cancer pain management. In: Aronoff GM, ed. Evaluation and Treatment of Chronic Pain. Baltimore, Md: Urban and Schwartzenberg; 1985b: 425–434.Google Scholar
  24. 24.
    Feinmann C. Pain relief by antidepressants: possible mode of action. Pain 1985; 23: 1–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Beecher HK. Pain in men wounded in battle. Ann Surg 1946; 123: 96–105.PubMedCrossRefGoogle Scholar
  26. 26.
    Mayer DJ, Liebeskind JC. Pain reduction by focal electrical stimulation of the brain: an anatomical approach. Brain Res 1974; 68: 73–93.PubMedCrossRefGoogle Scholar
  27. 27.
    Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969; 164: 444–445.PubMedCrossRefGoogle Scholar
  28. 28.
    Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation produced analgesia by naloxone, a narcotic antagonist. Science 1974; 191: 961–962.CrossRefGoogle Scholar
  29. 29.
    Hughes J, Smith TH, Kosterlitz JW, et al. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975; 258: 577–579.PubMedCrossRefGoogle Scholar
  30. 30.
    Pasternak GW, Goodman R, Snyder SH. An endogenous morphine like factor in mammalian brain. Life Sci 1975; 16: 1765–1769.PubMedCrossRefGoogle Scholar
  31. 31.
    Evans CJ, Hammond DL, Frederickson RCA. The opioid peptides. In: Pasternak GW, ed. The Opiate Receptors. Clifton, NJ: Humana Press; 1988: 23–74.CrossRefGoogle Scholar
  32. 32.
    Moulin DE, Max M, Kaiko RF, et al. Efficacy of intrathecal [D-AIa2,D-Leu5jenkephalin in cancer patients with chronic pain. Pain 1985; 23: 213–222.PubMedCrossRefGoogle Scholar
  33. 33.
    Martin WR. Opioid antagonists. Pharmacol Rev 1967; 19: 463–521.PubMedGoogle Scholar
  34. 34.
    Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science 1973; 179: 1011–1014.PubMedCrossRefGoogle Scholar
  35. 35.
    Terenius L. Characteristics of the `receptor’ for narcotic analgesics in synaptic plasma membrane fractions from rat brain. Acta Pharmacol Toxicol 1973; 33: 377–384.CrossRefGoogle Scholar
  36. 36.
    Simon EJ, Hiller JM, Edelman I. Stereo-specific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenates. Proc Natl Acad Sci USA 1973; 70: 1947 1949.Google Scholar
  37. 37.
    Pasternak GW, ed. The Opiate Receptors. Clifton, NJ: Humana Press; 1988.Google Scholar
  38. 38.
    Pasternak GW, Wood PL. Multiple mu opiate receptors. Life Sci 1986; 38: 1889–1898.PubMedCrossRefGoogle Scholar
  39. 39.
    Zukin RS, Eghbali M, Olive D, et al. Characterization and visualization of rat and guinea pig brain K opioid receptors: evidence for Ki and K2 opioid receptors. Proc Natl Acad Sci USA 1988; 85: 4061–4065.PubMedCrossRefGoogle Scholar
  40. 40.
    Pasternak GW, Childers SR, Snyder SH. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science 1980; 208: 514–516.PubMedCrossRefGoogle Scholar
  41. 41.
    Bodnar RJ, Williams CW, Lee SJ, et al. Role of mu’ opiate receptors in supraspinal opiate analgesia: a micro-injection study. Brain Res 1988; 447: 25–37.PubMedCrossRefGoogle Scholar
  42. 42.
    Payne R. Neck pain in the elderly: a mangement review, I. Geriatrics 1987a; 42: 59–65.PubMedGoogle Scholar
  43. 43.
    Payne R. Neck pain in the elderly: a managment review, II. Geriatrics 1987b; 42: 71–73.PubMedGoogle Scholar
  44. 44.
    Gandy S, Payne R. Back pain in the elderly: updated diagnosis and management. Geriatrics 1986; 41: 59–74.PubMedGoogle Scholar
  45. 45.
    Jefferys RV. The surgical treatment of cervical myelopathy due to spondylosis and disk degeneration. J Neurol Neurosurg Psychiatry 1986; 49: 353.CrossRefGoogle Scholar
  46. 46.
    Adams C. Cervical spondylotic radiculopathy and myelopathy. In: Vinken PGJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam, Holland: Elsevier Science Publishers; 1976, vol 26: Injuries of the Spine and Spinal Cord, pt 2, p 97.Google Scholar
  47. 47.
    Brooker AE, Barter AW. Cervical spondylosis: clinical study with comparative radiology. Brain 1965; 88: 925.PubMedCrossRefGoogle Scholar
  48. 48.
    Payne R. Back pain in the elderly. Geriatrics 1986; 41: 59–74.PubMedGoogle Scholar
  49. 49.
    Hall S, Bartleson JD, Onofrio B, et al. Lumbar spinal stenosis: clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med 1985; 103: 271–275.PubMedGoogle Scholar
  50. 50.
    Maistrelli GL, Vaughan PA, Evans DC, et al. Lumbar disc herniation in the elderly. Spine 1987; 12: 63–66.PubMedCrossRefGoogle Scholar
  51. 51.
    Hunder GG, Allen GL. Giant cell arteritis: a review. Bull Rheum Dis 1978; 29: 980–986.PubMedGoogle Scholar
  52. 52.
    Loeser JD. Herpes zoster and postherpetic neuralgia. Pain 1986; 25: 149–164.PubMedCrossRefGoogle Scholar
  53. 53.
    Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986; 20: 651–664.PubMedCrossRefGoogle Scholar
  54. 54.
    Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 1984; 7: 51–82.PubMedCrossRefGoogle Scholar
  55. 55.
    Taub A, Collins WF. Observations on the treatment of denervation dysethesia with psychotropic drugs: postherpetic neuralgia, anesthesia dolorosa, peripheral neuropathy. In: Bonica JJ, ed. Advances in Neurology. New York, NY: Raven Press; 1974; 4: 309–315.Google Scholar
  56. 56.
    Kori SH, Krol G, Foley KM. Computed tomographic evaluation of bone and soft tissue metastasis. In: Weiss L, Giklbert HA, eds. Bone Metastases, monograph series. 1981; 3: 245–257.Google Scholar
  57. 57.
    Jaeckle K, Young DF, Foley KM. The natural history of lumbosacral plexopathy in cancer patients. Neurology 1984; 33: 8–14.Google Scholar
  58. 58.
    Cherry DA, Gourlay GK, Cousins MJ. Epidural mass associated with lack of efficacy of epidural morphine and undetectable CSF morphine concentrations. Pain 1986; 25: 69–73.PubMedCrossRefGoogle Scholar
  59. 59.
    Coombs DW, Mauer LH, Saunders RL. Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control. J Clin Oncol 1984; 2: 1414 1420.Google Scholar
  60. 60.
    Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain 1984; 18: 83–95.PubMedCrossRefGoogle Scholar
  61. 61.
    Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report on 38 cases. Pain 1986; 25: 171–186.PubMedCrossRefGoogle Scholar
  62. 62.
    Inturrisi CE, Foley KM. Narcotic analgesics in the management of pain. In: Kuhar M, Pasternak G, eds. Analgesics: Neurochemical, Behavioral and Clinical Perspectives. New York, NY: Raven Press; 1984a;257288.Google Scholar
  63. 63.
    Pasternak GW, Bodnar RJ, Clark JA, et al. Morphine-6glucuronide, a potent mu agonist. Life Sci 1987; 41: 2845 2849.Google Scholar
  64. 64.
    Kaiko RF, Wallenstein SL, Rogers AG, et al. Narcotics in the elderly. Med Clin North Am 1982; 66: 1079–1089.PubMedGoogle Scholar
  65. 65.
    Kaiko RF, Wallenstein SL, Rogers AG, et al. Clinical analgesic studies and sources of variation in analgesic responses to morphine. In: Foley KM, Inturrisi, eds. Advances in Pain Research and Therapy. New York, NY: Raven Press; 1986; 8: 13–23.Google Scholar
  66. 66.
    Portenoy RK, Moulin DE, Rogers A, et al. IV infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 1986; 70: 575–581.PubMedGoogle Scholar
  67. 67.
    Bruera E, Brenneis C, MacDonald RN. Continuous sc infusion of narcotics for the treatment of cancer pain: an update. Cancer Treat Rep 1987a; 71: 953–958.PubMedGoogle Scholar
  68. 68.
    Raj PP, Kannar KD, Vigborth E, et al. Comparison of continuous epidural infusion of local anesthetic and administration of systemic narcotics in the management of pain after total knee replacement surgery. Anesth Analg 1987; 66: 401–406.PubMedCrossRefGoogle Scholar
  69. 69.
    Payne R. Role of epidural and intrathecal narcotics and peptides in the management of pain. Med Clin North Am 1987; 71: 313–327.PubMedGoogle Scholar
  70. 70.
    MacDonald RN, Bruera E, Brennels C, et al. Management of the narcotic bowel syndrome (NBS) in cancer patients using a continuous subcutaneous infusion of metoclopromide (SCIM). Pain 1987; 4 (suppl): S144.CrossRefGoogle Scholar
  71. 71.
    Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37: 589–596.PubMedCrossRefGoogle Scholar
  72. 72.
    Max MB, et al. Amitriptyline, but not lorazapam relieve posttherapeutic neuralgia. Neurology 1988; 38: 1427 1432.Google Scholar
  73. 73.
    Laska EM, Sunshine A, Mueller F, et al. Caffeine as an analgesic adjuvant. DAMA 1984; 251: 1711–1718.Google Scholar
  74. 74.
    Forrest WH, Brown BW, Brown CR, et al. Dextroamphetamine with morphine for treatment of postoperative pain. N Engl J Med 1977; 296: 712–715.PubMedCrossRefGoogle Scholar
  75. 75.
    Bellville JW, Forrest WH, Miller E, Brown BW. Influence of age on pain relief from analgesics: a study of postoperative patients. DAMA 1971; 217: 1835–1841.Google Scholar
  76. 76.
    Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180–185.PubMedCrossRefGoogle Scholar
  77. 77.
    Nies A, Robinson DS, Friedman MJ, et al. Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 1977; 134: 790–793.PubMedGoogle Scholar
  78. 78.
    Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1973; 78: 173–181.PubMedGoogle Scholar
  79. 79.
    American Pain Society. Principles of Analgesic Use in Acute Pain and Chronic Cancer Pain. In Press.Google Scholar
  80. 80.
    Foley KM. The treatment of cancer pain. N Engl J Med 1985; 313: 84–95.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Richard Payne
  • Gavril W. Pasternak

There are no affiliations available

Personalised recommendations